Lindsey Everline
Family · Coldwater, MINPI 1972016038
Payments from drug & device makers
Across 312 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$726
- GSK$572
- Lilly USA, LLC$524
- AbbVie$417
- AstraZeneca$371
- Mylan Specialty L.p.$321
- plus $3K from 24 others
What the payments were for
- Food & beverage$5,47398%
- Education$872%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $726 |
| GSK | 42 | $572 |
| Lilly USA, LLC | 30 | $524 |
| AbbVie | 30 | $417 |
| AstraZeneca | 20 | $371 |
| Mylan Specialty L.p. | 14 | $321 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $319 |
| Pfizer | 15 | $304 |
| Boehringer Ingelheim | 12 | $249 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $201 |
| Lundbeck LLC | 8 | $180 |
| Dexcom, Inc. | 8 | $150 |
| Exact Sciences | 7 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $135 |
| Biohaven Pharmaceuticals, Inc. | 9 | $134 |
| Bayer | 8 | $131 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Astellas Pharma US Inc | 2 | $90 |
| Johnson & Johnson | 5 | $79 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Merck | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Novartis | 2 | $46 |
| Abbott | 2 | $44 |
| Amarin Pharma, Inc. | 2 | $42 |
| Insulet Corporation | 1 | $20 |
| Amgen | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Phadia US Inc. | 1 | $12 |
How this compares
$5,560 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 106 | $109,265 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 126 | $106,427 |
| OzempicSemaglutide | 78 | $94,911 |
| EliquisApixaban | 65 | $58,682 |
| RexultiBrexpiprazole | 33 | $49,579 |
| TrulicityDulaglutide | 34 | $46,134 |
| MounjaroTirzepatide | 23 | $43,186 |
| JanuviaSitagliptin Phosphate | 26 | $36,059 |
| FarxigaDapagliflozin Propanediol | 54 | $33,492 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $31,664 |
| XareltoRivaroxaban | 22 | $26,488 |
| Spiriva RespimatTiotropium Bromide | 37 | $21,405 |
| RybelsusSemaglutide | 16 | $21,232 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 26 | $14,282 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 71 | $13,458 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $249 | $145,762173 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Breo Ellipta | $572 | $137,176197 claims |
| Novo NordiskOzempic, Rybelsus | $726 | $116,14394 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $524 | $89,32057 claims |
| PfizerEliquis | $304 | $58,68265 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere | $371 | $51,46288 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $114 | $49,57933 claims |
| MerckJanuvia | $61 | $36,05926 claims |
| Johnson & JohnsonXarelto | $79 | $26,48822 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $135 | $10,65714 claims |
| Astellas Pharma US IncMyrbetriq | $90 | $8,32511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Coldwater
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.